Orthopedic soft tissue repair devices market size to grow by USD 5,633.11 million from 2022 to 2027; The rising geriatric population across the globe will drive growth - Technavio
NEW YORK, March 24, 2023 /PRNewswire/ -- Technavio categorizes the global orthopedic soft tissue repair devices market size as estimated to increase by USD 5,633.11 million between 2022 and 2027. The market's growth momentum will be progressing at a CAGR of 11.05% during the forecast period. The growth of the market is driven by the rising geriatric population across the globe. In general, older adults heal more slowly than younger ones. Older people typically have low overall strength, flexibility, and balance compared to younger people. As a result, it is more challenging to make up for injury limitations and to resume daily activities. According to the Population Reference Bureau, by 2060, there will be 95 million Americans who are 65 years or older, up from an estimated 52 million in 2018. It is anticipated that the proportion of people 65 years and older will increase from 16% to 23%. As a result, there is a growing demand for both acute and long-term healthcare services, which is anticipated to drive the growth of the global orthopedic soft tissue repair devices market during the forecast period. Discover some insights on the market size historic period (2017 to 2021) and Forecast period (2023 to 2027) before buying the full report - Request a sample report
Global Orthopedic Soft Tissue Repair Devices Market - Segmentation Assessment Segment Overview Technavio has segmented the market based on product type (fixation devices, tissue scaffold, and cell therapy-based), and end-user (hospitals and clinics, ambulatory surgical centers, and physician's offices).
The market growth in the fixation devices segment will be significant during the forecast period. A fixation device is made of artificial material and its purpose is to replace the bone structure. This helps fix and support the bone as it heals from surgery or injury. Immobilization devices can be used for a variety of conditions, including fractures and sports injuries. Musculoskeletal injuries are the primary application for this type of fixation device. Some of the fixation devices are suture anchors and interference screws. Such factors will increase the growth of the segment over the forecast period.
Geography Overview By geography, the global orthopedic soft tissue repair devices market is segmented into North America, Europe, Asia, and Rest of World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the global orthopedic soft tissue repair devices market.
North America is estimated to contribute 45% to the growth of the global market during the forecast period. North America will bring a significant revenue share to the market in 2022. This is due to increased cases of trauma and knee arthroscopies in the region, as well as an increased number of amputations and sports injuries. Rising healthcare spending and investments in the infrastructure of the sector are also contributing significantly to the expansion of the region, as the cost of expensive orthopedic soft tissue repair surgeries can be reduced. Such factors are expected to boost the demand for orthopedic-related treatments, thus propelling the growth of the North American orthopedic soft tissue repair devices market during the forecast period.
For insights on global, regional, and country-level parameters with growth opportunities from 2017 to 2027 - Download a Sample Report
Global Orthopedic soft tissue repair devices market ? Vendor Analysis Vendor Landscape - The global orthopedic soft tissue repair devices market is fragmented, with the presence of several global as well as regional vendors. A few prominent vendors that offer orthopedic soft tissue repair devices in the market are Arthrex Inc., Becton Dickinson and Co., Boston Scientific Corp., Conmed Corp., Integra Lifesciences Holdings Corp., Johnson and Johnson, JRF Ortho, LifeCell International Pvt. Ltd., LifeNet Health Inc., Medtronic Plc, MTF Biologics, RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., Tissue Regenix Group Plc, Wright Medical Group NV, Zimmer Biomet Holdings Inc., Acera Surgical Inc., AlloSource, and Amplitude Surgical and others.
A few prominent vendors that offer global orthopedic soft tissue repair devices in the market include:
Boston Scientific Corp.: The company offers orthopedic soft tissue repair devices such as ACLip.
Conmed Corp.: The company offers orthopedic soft tissue repair devices such as FiberTak button, Knotless FiberTak soft anchor, and Corkscrew suture anchors.
Integra Lifesciences Holdings Corp.: The company offers orthopedic soft tissue repair devices such as XenMatrix AB Surgical Graft.
Johnson and Johnson: The company offers orthopedic soft tissue repair devices such as Fixate suturing devices, tissue bands, and Clik anchors.
Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
Global competitiveness and key competitor positions
Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial - Buy the report!
Global Orthopedic Soft Tissue Repair Devices Market ? Market Dynamics
Key Trends - The growing use of orthopedic devices in emerging economies is a significant trend shaping growth. In the next few years, soft tissue repair products will become more widely used in emerging countries of Asia and ROW. Vendors are expected to witness many growth?opportunities in?such countries. This is due to the fact that the markets in these countries are experiencing a significant patent base for targeted indications (cardiovascular, orthopedics, general and gynecological diseases), rising health awareness, increasing healthcare spending,?and?growth in medical tourism. Also, medical procedures in these developing countries are less expensive compared to that in developed nations. Therefore, such factors are expected to drive the growth of the market in emerging economies, over the forecast period.
Major challenges - The lack of availability of skilled personnel for the use of orthopedic soft tissue repair devices is a major challenge impeding the market growth. One of the major obstacles in the market is the shortage of qualified surgeons in both developed and developing countries. Technological developments in this field are rapidly changing the technology landscape and the areas in which soft tissue repair products are used. This requires physicians and other medical professionals to develop the skills necessary to use soft tissue repair products such as allografts, xenografts, and synthetic meshes. As a result, medical professionals in hospitals and clinics are reluctant to close wounds with cutting-edge surgical products. Therefore, factors like these will pose a major challenge to the growth of the global market during the forecast period. ?
Drivers, Trends, and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report! sample report!
What are the key data covered in this Orthopedic Soft Tissue Repair Devices Market report?
CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the orthopedic soft tissue repair devices market between 2023 and 2027
Precise estimation of the orthopedic soft tissue repair devices market size and its contribution to the market in focus on the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the orthopedic soft tissue repair devices market across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market's competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of orthopedic soft tissue repair devices market vendors
Gain instant access to 17,000+ market research reports.
The orthopedic device market size is expected to increase by USD 12.11 billion from 2022 to 2027, and the market's growth momentum will accelerate at a CAGR of 3.85%. The market is segmented by application (spine, knee, hip, extremities, and others), product (orthopedic implants and support devices and orthobiologics), and geography (North America, Europe, Asia, and Rest of World (ROW)).
The orthopedic implants marketsize is expected to increase by USD 15.45 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.73%. The market is segmented by product (Joint reconstruction implants, Spinal implants, and Craniomaxillofacial implants), and geography (North America, Europe, Asia, and Rest of World (ROW)).
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution
North America at 45%
US, Germany, France, UK, and Japan, Canada, Mexico, Italy,Spain, India, Japan, Australia, and South Korea
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled
Arthrex Inc., Becton Dickinson and Co., Boston Scientific Corp., Conmed Corp., Integra Lifesciences Holdings Corp., Johnson and Johnson, JRF Ortho, LifeCell International Pvt. Ltd., LifeNet Health Inc., Medtronic Plc, MTF Biologics, RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., Tissue Regenix Group Plc, Wright Medical Group NV, Zimmer Biomet Holdings Inc., Acera Surgical Inc., AlloSource, and Amplitude Surgical
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period.
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Table of contents:
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary ? Chart on Market Overview
Exhibit 02: Executive Summary ? Data Table on Market Overview
Exhibit 03: Executive Summary ? Chart on Global Market Characteristics
Exhibit 04: Executive Summary ? Chart on Market by Geography
Exhibit 05: Executive Summary ? Chart on Market Segmentation by Product Type
Exhibit 06: Executive Summary ? Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary ? Chart on Incremental Growth
Exhibit 08: Executive Summary ? Data Table on Incremental Growth
Exhibit 09: Executive Summary ? Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 141: Johnson and Johnson - Business segments
Exhibit 142: Johnson and Johnson - Key news
Exhibit 143: Johnson and Johnson - Key offerings
Exhibit 144: Johnson and Johnson - Segment focus
12.10 LifeNet Health Inc.
Exhibit 145: LifeNet Health Inc. - Overview
Exhibit 146: LifeNet Health Inc. - Product / Service
Exhibit 147: LifeNet Health Inc. - Key offerings
12.11 Medtronic Plc
Exhibit 148: Medtronic Plc - Overview
Exhibit 149: Medtronic Plc - Business segments
Exhibit 150: Medtronic Plc - Key news
Exhibit 151: Medtronic Plc - Key offerings
Exhibit 152: Medtronic Plc - Segment focus
12.12 MTF Biologics
Exhibit 153: MTF Biologics - Overview
Exhibit 154: MTF Biologics - Product / Service
Exhibit 155: MTF Biologics - Key offerings
12.13 RTI Surgical Inc.
Exhibit 156: RTI Surgical Inc. - Overview
Exhibit 157: RTI Surgical Inc. - Product / Service
Exhibit 158: RTI Surgical Inc. - Key offerings
12.14 Smith and Nephew plc
Exhibit 159: Smith and Nephew plc - Overview
Exhibit 160: Smith and Nephew plc - Business segments
Exhibit 161: Smith and Nephew plc - Key news
Exhibit 162: Smith and Nephew plc - Key offerings
Exhibit 163: Smith and Nephew plc - Segment focus
12.15 Stryker Corp.
Exhibit 164: Stryker Corp. - Overview
Exhibit 165: Stryker Corp. - Business segments
Exhibit 166: Stryker Corp. - Key news
Exhibit 167: Stryker Corp. - Key offerings
Exhibit 168: Stryker Corp. - Segment focus
12.16 Wright Medical Group NV
Exhibit 169: Wright Medical Group NV - Overview
Exhibit 170: Wright Medical Group NV - Business segments
Exhibit 171: Wright Medical Group NV - Key offerings
Exhibit 172: Wright Medical Group NV - Segment focus
12.17 Zimmer Biomet Holdings Inc.
Exhibit 173: Zimmer Biomet Holdings Inc. - Overview
Exhibit 174: Zimmer Biomet Holdings Inc. - Business segments
Exhibit 175: Zimmer Biomet Holdings Inc. - Key news
Exhibit 176: Zimmer Biomet Holdings Inc. - Key offerings
Exhibit 177: Zimmer Biomet Holdings Inc. - Segment focus
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 178: Inclusions checklist
Exhibit 179: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 180: Currency conversion rates for US$
13.4 Research methodology
Exhibit 181: Research methodology
Exhibit 182: Validation techniques employed for market sizing
Exhibit 183: Information sources
13.5 List of abbreviations
Exhibit 184: List of abbreviations
About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Limoneira Company (the "Company" or "Limoneira") , a diversified citrus growing, packing, selling and marketing company with related agribusiness activities and real estate development operations, today reported financial results for the second...
ICF , a global consulting and technology services provider, was recently awarded a contract by the U.S. Department of Justice Office for Victims of Crime (OVC) to provide training and technical assistance (TTA) to better support and serve victims and...
Cue Health , a healthcare technology company, announces an industry breakthrough as the first company to receive De Novo authorization from the U.S. Food and Drug Administration (FDA) for its Cue COVID-19 Molecular Test, designed for both home and...
Today, the U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test. The product is a molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material from SARS-CoV-2 virus...
Bayer AG is joining forces with Acuitas Therapeutics, Inc., a biotechnology company specializing in the development of lipid nanoparticle (LNP) delivery systems for molecular therapeutics. Acuitas' LNP technology will support Bayer's in vivo gene...
The "Dental Floss Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War" report has been added to ResearchAndMarkets.com's offering.
The global dental floss market is...